Filing Details
- Accession Number:
- 0001140361-21-009085
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-18 16:22:30
- Reporting Period:
- 2021-03-16
- Accepted Time:
- 2021-03-18 16:22:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1104506 | Insmed Inc | INSM | Pharmaceutical Preparations (2834) | 541972729 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1402051 | William Lewis | 700 Us Highway 202/206 Bridgewater NJ 08807 | Chair And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-03-16 | 50,000 | $3.40 | 229,608 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-16 | 23,639 | $35.65 | 205,969 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-03-16 | 26,061 | $36.66 | 179,908 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-03-16 | 300 | $37.18 | 179,608 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2021-03-16 | 50,000 | $0.00 | 50,000 | $3.40 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
130,630 | 2022-09-10 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- This is the weighted average sales price representing 23,639 shares sold at prices ranging from $35.18 to $36.13 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 26,061 shares sold at prices ranging from $36.15 to $37.04 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 300 shares sold at prices ranging from $37.05 to $37.25 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.